Recombinant SELL (Aselizumab Biosimilar) antibody

Catalog No. ABIN7597518

This Humanized Chimeric antibody specifically detects SELL (Aselizumab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant SELL (Aselizumab Biosimilar) antibody (ABIN7597518)

Target: SELL (Aselizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Grade: Research Grade

Product Details anti-SELL (Aselizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Aselizumab Biosimilar Antibody

Specificity: CD62 antigen-like family member L, Leukocyte adhesion molecule 1, CD62L, LYAM1, TQ1, SELL, Leukocyte-endothelial cell adhesion molecule 1, L-selectin, LAM-1, gp90-MEL, LNHR, LECAM1, Lymph node homing receptor, Leukocyte surface antigen Leu-8

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for SELL (Aselizumab Biosimilar)

Target: SELL (Aselizumab Biosimilar)

Alternative Name: Aselizumab Biosimilar

Target Type: Biosimilar

Background: CD62 antigen-like family member L, Leukocyte adhesion molecule 1, CD62L, LYAM1, TQ1, SELL, Leukocyte-endothelial cell adhesion molecule 1, L-selectin, LAM-1, gp90-MEL, LNHR, LECAM1, Lymph node homing receptor, Leukocyte surface antigen Leu-8

UniProt: P14151

CAS-No: 395639-53-9